Chronic Idiopathic Constipation clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 18 years and up
Prucalopride is a medicine used to treat constipation. The main aim of the study is to measure prucalopride concentrations in breast milk. Other aims are to check the growth and development of babies breastfed by their mothers who took prucalopride and to check if the babies had any side effects. During the study, participants will provide one set of milk samples over 24 hours using an electric breast pump. Breast milk samples will be collected at home and will be shipped to the laboratory. Also, participants will be asked questions during telephone interviews every 2 months in the first year of their baby's life. They will also be asked to complete growth and development questionnaires about their baby.
Our lead scientists for Chronic Idiopathic Constipation research studies include Christina Chambers, PhD, MPH.